Marinus Pharmaceuticals (NASDAQ:MRNS) Cut to Sell at StockNews.com

StockNews.com lowered shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) from a hold rating to a sell rating in a research note released on Wednesday morning. MRNS has been the subject of several other reports. Truist Financial reduced their target price on shares of Marinus Pharmaceuticals from $32.00 to $25.00 and set a buy rating […]

Related Keywords

Canada ,Blackrock ,Nova Scotia ,Lion Point ,Northwest Territories , ,Institutional Trading Of Marinus Pharmaceuticals ,Marinus Pharmaceuticals Stock ,Marinus Pharmaceuticals ,Analyst Recommendations For Marinus Pharmaceuticals ,Marinus Pharmaceuticals Inc ,Blackrock Inc ,Eventide Asset Management ,Royal Bank ,Franklin Resources Inc ,News Ratings For Marinus Pharmaceuticals Daily ,Free Report ,Moderate Buy ,Get Free Report ,Asset Management ,Point Capital ,Marinus Pharmaceuticals Daily ,